 12. Organization: The principal investigator will be Professor Jiguang Wang from the Centre for Epidemiological Studies and Clinical Trials, Ruijin Hospital, Shanghai, China. Professor Yan Li from the same centre will be the coordinator of the trial. 20 research oriented hospitals will participate in the recruitment of the study subjects. At least 20 subjects should be recruited in each of the participating hospitals. 